Mitsubishi Gas Chemical Company, Inc. (MGC), a chemical and life science technology company, He founded an emergency medicine and food allergy management company with the goal of transforming allergy diagnosis and treatment around the world.
The collaboration aims to develop comprehensive, personalized allergy care strategies that improve patient outcomes and quality of life.
Key elements of the collaboration include the companies’ joint efforts to bring a cutting-edge allergy diagnostic platform to the U.S. market and integrate food allergy technologies aimed at creating a holistic view for personalized allergy care.
This partnership is in line with MGC’s long-term plan to target the medical and food sectors.
“This partnership with MGC marks an important milestone in our mission to improve the lives of millions of people affected by allergies,” Allergé founder and CEO Javier Evelyn said in a statement.
“By combining our forces, we will be able to deliver unprecedented advances in allergy diagnosis and management.”
The two companies say that by working together, they aim to transform the lives of people with food allergies by combining better testing with innovative treatments.
“The two companies aim to set a new standard in allergy care by combining our technologies and expertise to address unmet needs in both the U.S. and Japanese markets,” MGC executive director and director Yoshinori Isahaya said in a statement.
Larger trends
Other organizations involved in food allergies include: In 2017, Harvard Medical School developed a point-of-use food allergen detector that attaches to a key fob and can perform testing in minutes. The device is designed to detect key antigens with sensitivity well below regulatory limits.
In 2016, 6SensorLabs, a smartphone-enabled allergen testing company, rebranded under the name Nima and raised $9.2 million to develop a range of food testing devices. Nima used the funding to sell food sensors for peanuts and dairy products.
In 2023, Alerje was awarded a Phase II grant from the National Science Foundation’s Small Business Innovation Research Program. The $1 million grant was used to increase capacity of the company’s AI digital platform and scale up manufacturing of its epinephrine auto-injector solution.
